EX-10.1



 Exhibit 10.1 

Execution Version 

CONFIDENTIAL AGREEMENT 

This Confidential Agreement (the “Agreement”) is made and entered into this 30th day of June, 2015 (the
“Effective Date”), by and between (a) Nobilis Health Corp., a British Columbia corporation (“Parent”), (b) Northstar Healthcare Subco, LLC, a Delaware limited liability company
(“Subco,” and, together with Parent, “Nobilis”), (c) Athas Health, LLC, a Texas limited liability company (“Athas”), (d) North American Laserscopic Institute, LLC, a
Texas limited liability company (“NALSI”), and (d) the other persons executing this Agreement as reflected on the signature pages hereto (collectively, the “Athas Sellers”). Nobilis, Athas and the
Athas Sellers may be referred to collectively as the “Parties,” or as appropriate, any one of the Parties may be referred to as “Party.” Capitalized words not otherwise defined herein are defined in
the MIPA (defined below). In exchange for the Consideration set forth below (as defined herein), the Parties agree to all of the terms and conditions stated herein, including the recitals, which are of material
consideration hereto:  
 RECITALS 

WHEREAS, Nobilis and Athas Sellers are parties to that certain Membership Interest Purchase Agreement (the
“MIPA”) dated as of November 26, 2014 (the “Closing Date”), which is attached hereto as Exhibit 1, whereby Subco purchased 100% of the membership interest in Athas (the “Membership
Interest”) from the Athas Sellers; 
 WHEREAS, as additional consideration for the purchase of the
Membership Interest, the Athas Sellers are currently owed, in the aggregate, 4,666,667 shares of Nobilis common stock, of which half was to be paid to the Athas Sellers on the first anniversary of the MIPA’s closing date and half was to be paid
on the second anniversary of the MIPA’s closing date (collectively, the “Contingent Shares”); 

WHEREAS, pursuant to the MIPA, Nobilis’ sole remedy against the Athas Sellers for breach of the MIPA’s representations and
warranties (other than the Fundamental Reps) is in the form of a reduction in the number of Contingent Shares issuable to the Athas Sellers pursuant to Section 2.4 and Section 2.5 of the MIPA; 

WHEREAS, Nobilis believes it is entitled to indemnity from the Athas Sellers, pursuant to Article XI of the MIPA, for
certain losses incurred by Nobilis related to the matter styled RIVERVIEW HEALTH INSTITUTE LLC vs NORTH AMERICAN LASERSCOPIC SPINE INSTITUTE LLC, Civil Action Number 2012CV08393 in the Common Pleas Court of Montgomery County, Ohio, (the
“RHI Litigation”), and that it will likely be entitled to indemnity for certain expenses and other losses likely to be incurred as the result of certain claims and causes of action asserted against North American Laserscopic
Spine Institute, LLC, which are listed on the attached Schedule 1 (the “NALSI Litigation”); 

WHEREAS, Nobilis also believes that it is or may be entitled to recover from the Athas Sellers independently of the MIPA expenses borne by
Athas and Nobilis related to or arising out of the NALSI Litigation, for which the Athas Sellers should have been liable and which total, in 







 
the aggregate, One Million Seven Hundred Thousand Dollars ($1,700,000.00) (the “NALSI Expenses”), and Nobilis believes that it will be entitled to collect from the Athas
Sellers, personally, Eight Hundred Fifty Thousand Dollars ($850,000.00) which represents the principal balance of the outstanding promissory note made by NALSI in favor of Athas (the “NALSI Note”) to cover certain expenses
related to NALSI, all of which the Athas Sellers have contested; 
 WHEREAS, Nobilis has asserted, and the Athas Sellers have
contested, that they would equally share in the expenses incurred by Nobilis and Athas as the result of the matter styled ELITE AMBULATORY SURGERY CENTERS LLC vs. ATHAS HEALTH LLC, Civil Action Number 201514396 in the Harris County, Texas, Superior
Court (the “Elite Litigation”);  
 WHEREAS, the Athas Sellers have asserted, and
Nobilis has contested, that the Lock Up Period (as defined therein) in the Registration Rights Agreement by and among Parent and the Athas Sellers dated as of the Closing Date (the “Registration Rights Agreement”) was
terminated as the result of Parent’s private placement that closed on May 13, 2015, and that the Athas Sellers are now entitled to the lifting of the Lock-Up on the Closing Shares (the “Lock-Up Claims”) pursuant to
Section 3.4(d) of the Registration Rights Agreement;  
 WHEREAS, the matters described in these recitals
are the hereinafter referred to as the “Disputes”; 
 WHEREAS, each Party denies all of the claims
alleged against it related to or arising out of the Disputes; and 
 WHEREAS, in order to avoid further time, expense and uncertainties of
litigation, the Parties desire to settle and resolve their differences in accordance with the terms and conditions set forth herein. 
 NOW,
THEREFORE, in consideration of the respective promises and the Consideration of the Parties set forth herein, the Parties hereby agree to compromise and settle all disputes between them relating to the matters made the basis of the Disputes, or
related to or arising out of the Disputes, as more fully set forth in the Disputes, and as more fully set forth herein. 
  

	I.	Consideration 

  

	 	A.	Waiver of Membership Interest Purchase Agreement Indemnity. The Parties hereby irrevocably waive the MIPA’s Article XI in its entirety. 


 

	 	B.	Consideration from the Athas Sellers. 

  

	 	1.	 Reduction of Number of Issuable Contingent Shares. The aggregate number of shares of Nobilis common stock (“Common
Shares”) owed by Nobilis to the Athas Sellers as Contingent Shares shall be reduced by Eight Hundred Thirty Six Thousand Twenty Nine (836,029) Common Shares, allocated among the Athas Sellers as set forth on Schedule 4 (the
“Withheld Shares”) such that Nobilis shall owe the Athas Sellers, in the aggregate, Three Million Eight Hundred Thirty Thousand Six Hundred 










	 	
Thirty Seven (3,830,637) Common Shares (the “Settlement Shares”). The Parties agree that the Withheld Shares shall be credited against and shall extinguish the NALSI
Expenses and the NALSI Note. 

  

	 	2.	Sales Restrictions. From the Effective Date until July 1, 2016, the Athas Sellers shall not sell, contract to sell (including any short sale or other hedging transaction), or otherwise dispose of, or grant
any option to purchase or otherwise transfer any Closing Shares or Settlement Shares, except: 

  

	 	a.	Through private brokered or “block” sales pursuant to Rule 144 of the Securities Act of 1933, as amended (the “Securities Act”), if available at the time of sale, or other available
exemption from registration under the Securities Act, for sale in the United States.  

  

	 	b.	Through controlled sales by and through PI Financial Corp. or Mackie Research Capital Corporation, where such sales are conducted after giving prior written notice to Nobilis and in a manner designed to protect the
trading price of the Common Shares. Athas Sellers hereby agree to permit PI Financial Corp. or Mackie Research Capital Corporation, as applicable, to consult with Nobilis with respect to such trading strategies for any sales conducted pursuant to
this provision. 

  

	 	c.	Each Athas Seller who will have received, after giving effect to this Agreement, an aggregate number of Closing Shares and Settlement Shares that is equal to or less than 150,000, may sell shares: 


 

	 	i.	in an amount that shall not exceed, in the aggregate over any 30 consecutive trading days, that number of shares which equals 1/3 of such Athas Seller’s aggregate holdings of Common Shares as of the Effective Date,
and 

  

	 	ii.	in an amount that shall not exceed, on any given trading day, 5,000 shares. 

  

	 	d.	Athas Sellers may make sales or purchases of additional shares of Common Stock that are acquired on the open market after the Effective Date of this Agreement; 


 

	 	e.	Athas Sellers may transfer Closing Shares or Settlement Shares between one or more other Athas Sellers, subject to this Agreement; 

  

	 	f.	Athas Sellers may transfer shares with the prior written consent of Parent, which may be granted or withheld in Parent’s sole discretion; 









	 	g.	if an Athas Seller is a corporation, limited liability company, partnership or trust, such Athas Seller may transfer its Closing Shares or Settlement Shares to any Affiliate (as defined in the Registration Rights
Agreement); and 

  

	 	h.	if an Athas Seller is an individual, such Athas Seller may transfer its Closing Shares or Settlement Shares by gift, will or intestacy to one or more Immediate Family Member (as defined in the Registration Rights
Agreement) or to a trust or partnership, the beneficiaries or partners of which are exclusively the Athas Seller or the Athas Seller’s Immediate Family Member(s); provided, however, that in such case it shall be a condition to such transfer
that the transferee execute an agreement stating that the transferee is receiving and holding such Common Shares subject to the provisions of this Agreement, and provided further that such transfer not involve a disposition for value.


 In order to assure the Athas Sellers of their ability to utilize Rule 144 as described in Section 2a above, Nobilis
hereby covenants (i) to respond to requests for transfer of Closing Shares or Settlement Shares (and removal of restrictive legends thereon) within five business days of the date that Rule 144 paperwork is submitted on behalf of an Athas Seller
by the applicable securities brokerage firm and (ii) to provide the opinion of counsel within such time period at its expense to Nobilis’ transfer agent that may be required for the transfer of such Common Shares pursuant to Rule 144. 

 

	 	3.	Releases by Athas Sellers. The Athas Sellers shall provide the releases set forth in Section III. 

  

	 	C.	Consideration from Nobilis and Athas.  

  

	 	1.	 Payment of Settlement Shares. Effective as of the Effective Date, Nobilis has authorized for issuance to each Athas Seller the Settlement
Shares in the amounts listed across from each such Athas Seller’s name on the treasury order, the form of which is attached as Schedule 3, and Nobilis covenants to provide the applicable certificates for such Settlement Shares on the
earlier of (i) the date that is fifteen (15) business days following the Effective Date and (ii) the date on which Parent receives required approvals from both the NYSE MKT and the TSX regarding the issuance of Common Shares subject
to such treasury order. Nobilis covenants to complete all required listing applications of the NYSE MKT and the TSX no later than August 31, 2015 and respond diligently to all requests of the NYSE MKT and TSX in connection therewith. In any
event, Nobilis agrees that the holding period for Rule 144 purposes in respect of Settlement Shares shall commence with the authorization of such issuance as of the Effective Date. The Athas Sellers hereby jointly and severally represent and warrant
that the number of Settlement Shares listed across 










	 	
from each such Athas Seller’s name represents all of the Settlement Shares to which such Athas Seller is entitled and that the amounts listed were determined solely by the mutual agreement
of the Athas Sellers. Nobilis shall have no liability to any Athas Seller for any disputes arising out of or related to the amount or number of Settlement Shares such Athas Seller receives or is entitled to receive, including, without limitation,
any disputes related to the proportion of Withheld Shares attributable to such Athas Seller. 

  

	 	2.	NALSI Litigation Expenses. Nobilis shall assume all expenses related to the defense of the NALSI Litigation; provided however, that nothing in this Agreement shall be construed to mean that Nobilis shall
assume or take any responsibility for the financial satisfaction of any judgment or settlement against NALSI related to or arising out of the NALSI Litigation. 


 

	 	3.	Elite Litigation Expenses. Nobilis shall assume all expenses related to or arising out of the Elite Litigation; provided however, that nothing in this Agreement shall be construed to mean that Nobilis
shall assume or take any responsibility for the financial satisfaction of any judgment against Athas or any of its subsidiaries related to or arising out of the Elite Litigation.  


 

	 	4.	Cash Payment to NALSI for NALSI Litigation Settlement. Upon execution of this Agreement, Nobilis shall make a wire transfer of immediately available funds to NALSI account(s) and in the amounts listed on the
wiring instructions in the attached as Schedule 2. NALSI shall use these funds solely for the purpose of paying the settlement and expenses related to the NALSI Litigation and legal expenses related to this Agreement. 


  

	 	5.	Removal of Restrictive Legends. Parent shall immediately instruct its transfer agent to remove any existing legends related to the contractual lock up from the Closing Shares. Nobilis further covenants that
certificates representing the Settlement Shares will not contain any restrictive legends other than those required by the Securities Act or the TSX. 

  

	 	6.	 Registration of Closing Shares and Settlement Shares. Nobilis shall to use commercially reasonable efforts to include such of the Closing
Shares and Settlement Shares that Athas Sellers elect to include, pursuant to their rights under the Registration Rights Agreement, for registration in the Registration Statement on Form S-1 pursuant to the Securities Act being prepared by Parent
pursuant to the Underwriting Agreement by and between Parent and Mackie Capital Research (“Mackie”) dated as of May 13, 2015. Athas Sellers acknowledge that the inclusion of the Closing Shares and Settlement Shares is
subject to Mackie’s consent. In the event that Mackie does not consent to the inclusion of the Closing Shares and 










	 	
the Settlement Shares in the Registration Statement, Nobilis acknowledges that it is bound by the terms of Section 2 of the Registration Rights Agreement. 


 

	 	7.	Releases by Nobilis, Athas and NALSI. Nobilis, Athas and NALSI shall provide the releases set forth in Section II. 

  

	 	8.	Several Liability. Nobilis hereby agrees that, from and after the Effective Date, it shall only be entitled to seek indemnification under Section 11.1 of the MIPA on a several
basis from the Sellers (as defined in the MIPA) who are not Parties hereto (individually, a “Non-Party Seller,” and two or more are “Non-Party Sellers”) 


On the Effective Date, the indemnification provided for in the MIPA’s Article XI shall terminate with respect to claims for indemnity
between any Party to this Agreement and no Party shall bring any claim pursuant to such Article XI thereafter; provided, however, the foregoing shall not apply with respect to the Non-Party Sellers as set forth in Section I(C)(8) above. 

 

	 	D.	Section A, Section B, Section C and Section D of this Section I are the “Consideration”. 


 

	II.	Releases by Nobilis, Athas and NALSI  

 Nobilis, Athas and NALSI each (on behalf of
itself and its respective subsidiaries) do hereby fully RELEASE, ACQUIT AND FOREVER DISCHARGE each of the Athas Sellers (and their respective affiliates), individually and collectively, and Chris Lloyd, individually and in his capacities as an
officer, director and/or manager of each Nobilis, Athas and NALSI (and each of their respective subsidiaries), from any and all claims, demands, causes of action, liabilities, expenses or costs of any character or nature, known or unknown, asserted
or that could have been asserted (i) in the Disputes, and/or which arise out of the matters made or that could have been made the basis of the Disputes, or (ii) in connection with the negotiation and execution of this Agreement, in each
case including, but not limited to, any and all claims, arising out of contracts, torts, or property rights, whether arising under statutory or common law, at law or in equity, that are now recognized by law, statute, regulation, judicial decision,
INCLUDING, BUT NOT LIMITED TO, the following: all actual damages; exemplary, treble or punitive damages, penalties of any kind; loss of income; common law and statutory penalties; damages to real or personal property or property rights; economic or
business losses; all claims for attorneys’ fees and costs; prejudgment and post-judgment interest, and injunctive relief. This release does not apply to the performance by an Athas Seller of its respective obligations under this Agreement or
otherwise to any breach of this Agreement and any matter not contemplated by subparts (i) and (ii) of this Section II. 
  

	III.	Releases by Athas Sellers  

 Each Athas Seller (on behalf of itself and its affiliates)
does hereby fully RELEASE, ACQUIT AND FOREVER DISCHARGE (a) Chris Lloyd, individually, and in his capacity as an 







 
officer, director and/or manager of each of Nobilis, Athas and NALSI (and each of their respective subsidiaries), (b) Steven Ganss in his capacity as Seller Representative, and (c) each
of Nobilis, Athas and NALSI (and each of their respective subsidiaries) from any and all claims, demands, causes of action, liabilities, expenses or costs of any character or nature, known or unknown, asserted or that could have been asserted
(i) in the Disputes, and/or which arise out of the matters made or could have been made the basis of the Disputes, or (ii) in connection with the negotiation and execution of this Agreement, in each case including, but not limited to, any
and all claims, arising out of contracts, torts, or property rights, whether arising under statutory or common law, at law or in equity, that are now recognized by law, statute, regulation, judicial decision, INCLUDING, BUT NOT LIMITED TO, the
following: all actual damages; exemplary, treble or punitive damages, penalties of any kind; loss of income; common law and statutory penalties; damages to real or personal property or property rights; economic or business losses; all claims for
attorneys’ fees and costs; prejudgment and post-judgment interest, and injunctive relief. This release does not apply to the performance by Nobilis, Athas or NALSI of their respective obligations under this Agreement and any matter not
contemplated by subparts (i) and (ii) of this Section III. 
  

	IV.	Indemnity.  

  

	 	A.	Lloyd and Ganss Indemnity. Nobilis shall indemnify and hold harmless Chris Lloyd, individually and in his capacity as an officer, director and/or manager of Nobilis or Athas, and Steven Ganss in his capacity as
Seller Representative, from and against any losses, including reasonable attorney’s fees, for any claims brought by any Non-Party Seller related to or arising out of (i) the Disputes or the matters made the basis of the Disputes, or
(ii) in connection with the negotiation and execution of this Agreement. 

  

	 	B.	Athas Seller Indemnity. Nobilis shall indemnify and hold harmless each Athas Seller, individually, from and against any losses, including reasonable attorney’s fees, related to any judgment for which an
Athas Seller would be personally liable (which, for clarity, does not include liability in his or her capacity as an officer, director and/or manager of NALSI or Athas) that is entered in either the Elite Litigation or the NALSI Litigation.


  

	V.	Warranties  

  

	 	1.	The Parties warrant and represent to each other that each has the authority to bind himself/herself/itself hereunder in the capacities stated herein, that each is competent to execute this Agreement and was fully
informed of its terms, contents, conditions, and effects before executing this instrument, and that in executing this Agreement, no promise or representation of any kind has been made to them, except as expressly stated in this Agreement. The
Parties represent that they have relied solely upon their own judgment after consulting with counsel, that neither is relying on any representation of another Party or another Party’s counsel except as contained in this Agreement, and that they
fully understand the terms of this Agreement and that the Consideration mentioned is all the Consideration to be received for the claims released herein and the execution of this Agreement. 









	 	2.	The Parties represent and warrant that this Agreement and the Consideration and the respective releases provided in Sections II and III (collectively, the “Releases”) are being made by the
Parties as a final compromise and settlement of disputed claims and causes of action, and that such Agreement and Consideration and Releases are not to be construed as an admission of liability of any fact on the part of any Party. The Parties have
expressly denied any liability to one another. It is contracted that neither this Agreement, nor the compromise and settlement agreement evidenced hereby, shall be used against any Party as evidence of liability or for estoppel in any suit, claim or
proceeding of any nature. However, this Agreement may be asserted by either Party (a) as an absolute and final bar to any claim or proceeding now pending or hereafter brought by any person, firm or corporation claiming by, through or under the
other Party alleging claims related to the subject matter of the Disputes or the Agreement, or (b) in any action to enforce the terms of this Agreement.  


 

	 	3.	By the signatures below, the Parties represent and warrant that the undersigned signatories are authorized to execute this Agreement and understand that this Agreement constitutes a final and complete release of claims
as more fully set forth above. 

  

	VI.	Successors and Assigns 

 This Agreement is binding upon and inures to the benefit of the
Parties, in all capacities, including their parent, subsidiary and affiliate corporations, attorneys, officers, directors, employees, agents, successors, heirs, predecessors, assigns and legal representatives, and anyone claiming by, through or
under them. As part of the consideration, the Parties expressly represent and warrant for themselves, and their parent, subsidiary and affiliate corporations, attorneys, officers, directors, employees, agents, successors, heirs, predecessors,
assigns and legal representatives that (1) the undersigned is legally competent and authorized to execute this Agreement, and (2) the Party has not assigned, pledged or otherwise in any manner whatsoever sold or transferred any right,
title or interest which it had or may have in the claims hereby released or the Disputes. 
  

	VII.	Confidentiality 

 In exchange for the Consideration and Releases herein, and except as
may be required for the dismissal of the Lawsuit and related proceedings, or the enforcement or carrying out the terms of this Agreement, the Parties agree to keep the nature and terms of this Agreement, and the Consideration, as well as any
negotiations relating thereto (referred to collectively as “Confidential Information”), confidential through, and further agree not to divulge Confidential Information to any persons (including, but not limited to, any
experts, third parties, consultants, witnesses, and/or agents or representatives of the press of media), except to their attorneys, 







 
accountants, financial advisors and like professionals, as reasonably necessary, in the ordinary course of handling the Disputes and the ordinary course of business and as required by law. Public
dissemination and disclosure to the press or media shall not be deemed to be in the ordinary course of handling the Disputes or the ordinary course of business. If inquiry is made, a Party may respond that the Disputes have been amicably resolved or
settled by mutual agreement. The Parties acknowledge that the harm caused by a breach of this Confidentiality provision is difficult to estimate or incapable of estimation, and that any breach of this Confidentiality provision shall entitle a
non-breaching Party to immediate injunctive relief, together with all costs and fees associated with seeking such relief. Notwithstanding the foregoing provisions, in the event that Nobilis should be required by applicable law (which, for the
avoidance of doubt, includes obligations pursuant to the Securities Act and the Securities Exchange Act of 1934, as amended) or legal process to disclose any Confidential Information, or to the extent that, in Nobilis’ counsel’s reasonable
discretion, disclosure of the terms of this Agreement is necessary to effectuate the purpose of this Agreement (which, for the avoidance of doubt, includes disclosure in connection with any registration of the Closing Shares and the Settlement
Shares under the Securities Act), such disclosure shall not constitute a breach of this Confidentiality provision. 
  

	VIII.	No other representations  

 All agreements and understandings of all parties are embodied
and expressed in this Agreement; and no other representation of any kind has been made to either Party with respect to this settlement by the other Party or any other person, firm, association, corporation, or other entity acting on its behalf
except as expressly set forth herein. 
  

	IX.	Severability  

 The provisions of this Agreement are severable. If for any reason any
provision of this Agreement is determined to be invalid, unenforceable, or contrary to any existing or future law to any extent, such provision shall be enforced to the extent permissible under the law and such invalidity, unenforceability, or
illegality shall not impair the operations of or otherwise affect those portions of this Agreement which are valid, enforceable, and legal. No Party to this Agreement shall initiate any proceeding challenging the validity or enforceability of any
provision of this Agreement once it has been signed. The Parties reserve only their right to enforce the terms and provisions of this Agreement to the extent that they are not fully performed by any other Party. 

 

	X.	Governing Law  

 This Agreement is entered into, and shall be governed by, construed in
accordance with, and enforced under the laws of the State of Texas. The terms and conditions contained in this Agreement are not mere recitals, but are obligations binding the Parties in accordance with, and to the fullest extent of, Texas law. 

 

	XI.	Construction  

 This Agreement has been prepared jointly by the Parties, and each Party
has had an opportunity to consult with legal counsel concerning its content. No ambiguity in the language of 







 
this Agreement shall be construed against any Party, and no presumption or burden of proof shall arise favoring or disfavoring any Party because of the authorship of any provision of this
Agreement. 
  

	XII.	Entire Agreement  

 This Agreement is a fully integrated agreement. It contains the full
and final expression of the Parties relative to its subject matter and all the promises and covenants exchanged by the Parties. This Agreement constitutes the entire contract between the Parties and supersedes any and all prior or contemporaneous
agreements, communications, or understandings, whether written or unwritten, between or among any of the Parties with respect to the matters set forth herein. It is intended by the Parties that this Agreement shall be complete and shall not be
subject to the claim of mistake of fact or law by the Parties. It is expressly understood and agreed that this Agreement may not be altered, amended, modified, or otherwise changed in any respect whatsoever except by an executed written agreement.
The Parties hereto agree that they will make no claim at any time or place that this Agreement has been orally altered or modified or otherwise changed by oral communication of any kind or character. The waiver by either Party hereto of any breach
of any provision of this Agreement shall not constitute or operate as a waiver of any breach or any other provision herein, nor shall failure to enforce any provision herein operate as a waiver at such time or at any future time of performance of
any other provision herein. 
  

	XIII.	Counterparts  

 This Agreement may be executed in one or more counterparts by each Party
hereto (including by facsimile or .pdf file by electronic mail), each of which shall be deemed to be an original and all of which taken together shall constitute one and the same Agreement. 

[Remainder of page intentionally left blank. Signature pages follows.] 







 IN WITNESS WHEREOF, the undersigned have caused this Agreement to be duly executed and delivered
on the date inscribed below their respective signatures, and the individuals signing this Agreement warrant and represent that they have the authority to bind themselves and the Parties to the terms of this Agreement. 

 

			
	Subco:
	
	Northstar Healthcare Subco, LLC
		
	By:	 	 /s/ Matthew K. Maruca

	Matthew K. Maruca, General Counsel
	
	NOBILIS:
	
	Nobilis Health Corp.
		
	By:	 	 /s/ Kenneth J. Klein

	Kenneth J. Klein, CFO
	
	ATHAS:
	
	Athas Health, LLC
		
	By:	 	 /s/ Andy Chen

	Andy Chen, CFO
	
	NALSI:
	
	North American Laserscopic Institute, LLC
		
	By:	 	 /s/ Chris Lloyd

	Chris Lloyd, CEO

 [Signatures continue on next page] 








			
	ATHAS SELLERS:
	
	 /s/ Chris H. Lloyd

	Chris H. Lloyd
	
	The Wells Children’s Irrevocable Trust
		
	By:	 	 /s/ Jay V. Wells

	Name:	 	 Jay V. Wells

	Title:	 	 Trustee

	
	The Vance Wells Irrevocable Asset Trust
		
	By:	 	 /s/ Vance Wells

	Name:	 	 Vance Wells

	Title:	 	 Trustee

	
	The Kym Wells Irrevocable Asset Trust
		
	By:	 	 /s/ Kym Wells

	Name:	 	 Kym Wells

	Title:	 	 Trustee

	
	 /s/ Vance Wells

	Vance Wells
	
	The Ganss Irrevocable Trust
		
	By:	 	 /s/ Carter Ganss

	Name:	 	 Carter Ganss

	Title:	 	 Trustee

	
	The Steven Ganss Irrevocable Asset Trust
		
	By:	 	 /s/ Steven Ganss

	Name:	 	 Steven Ganss

	Title:	 	 Trustee


 [Signatures continue on next page] 

  
 12 









			
	The Amy Ganss Irrevocable Asset Trust
		
	By:	 	 /s/ Amy Ganss

	Name:	 	 Amy Ganss

	Title:	 	 Trustee


  

	
	 /s/ Steve Ganss

	Steve Ganss
	
	 /s/ Alex Noffsinger

	Alex Noffsinger
	
	 /s/ Nick Lloyd

	Nick Lloyd
	
	 /s/ Tyler Holland

	Tyler Holland
	
	 /s/ Lewis Lefko

	Lewis Lefko
	
	 /s/ Brett Lamb

	Brett Lamb
	
	 /s/ Doug Johnson

	Doug Johnson
	
	 /s/ Christopher Smith

	Christopher Smith
	
	 /s/ John Lookabaugh

	John Lookabaugh
	
	 /s/ Jonathan Herland

	Jonathan Herland
	
	 /s/ Greg Campbell

	Greg Campbell

 [Signatures continue on next page] 

  
 13 









			
	 /s/ Brad Nelson

	Brad Nelson
	
	 /s/ Keith Crider

	Keith Crider
	
	 /s/ Christopher Quinn

	Christopher Quinn
	
	 /s/ Erin Bouck

	Erin Bouck
	
	 /s/ Chance McElhaney

	Chance McElhaney
	
	Cottonwood Family Trust
		
	By:	 	 /s/ Shelley Arnette

	Name:	 	 Shelley Arnette

	Title:	 	 Trustee

	
	 /s/ Melanie Gross

	Melanie Gross


  
 14 








 Schedule 1 

NALSI Litigation 
 Riverview Health
Institute, LLC, Fallang Family Limited Partnership v. North American Laserscopic Spine Institute, LLC, Christopher H. Lloyd, Joe S. Bailey, Sr., and Steven Ganss in the Court of Common Pleas, Montgomery County, Ohio, Case No. 2012 CV 08393.

 Nicholas Vanderburg v. North American Laserscopic Spine Institute, LLC, et. al., in the Court of Common Pleas of Montgomery County, Ohio, Case
No. 2014 CV 05607. 
 Judah Wolf et. al. v. North American Laserscopic Spine Institute, LLC et. al., in the Common Pleas Court of
Montgomery County, Ohio, Civil Division, Case No. 2010 CV 03165. 

  
 15 








 Schedule 2 

Wire Instructions 
  

									
	 Due to:
	  	Account No:	  	Routing No:	  	Amount:	 
	 NALSI
  

For payment to:
  

Riverview Health Institute, LLC, Fallang Family Limited Partnership and their attorneys
	  		  		  	$	2,700,000.00	  


  
 16 








 Schedule 3 

Treasury Order 
 [See attached]


  
 17 








 FORM OF TREASURY ORDER 

 

			
	TO:	  	CST Trust Company (“CST”)
		  	Attn: CTA Administration: cta_admin@canstockta.com
		  	320 Bay Street, 3rd Floor
		  	Toronto, ON M5H 4A6
		
	FROM:	  	NOBILIS HEALTH CORP.

  
 Upon
delivery of this treasury share direction, the undersigned (the “Corporation”) hereby authorizes and directs CST to issue and deliver, a total of
[                ] common shares from the Corporation’s treasury (the “Treasury Shares”) as of
[                ] in favor of the holders listed in the attached Schedule “A” for the number of Treasury Shares set forth opposite the names listed, and this
shall be your good and sufficient authority for so doing. 
 All certificates representing the Treasury Shares shall bear the legends set
forth in the attached Schedule “A”. 
 The Corporation hereby certifies that the aforementioned Treasury Shares have been duly
allotted to the securityholder listed in Schedule “A” and that the Corporation has received full consideration therefor, and that the Treasury Shares are therefor to be issued as fully paid and non-assessable. 

The Treasury Shares are issued pursuant to the Confidential Agreement effective as of June 30, 2015 by and among the Corporation and
certain other parties named therein. 
 Dated this      day of             ,
2015 
  

					
	NOBILIS HEALTH CORP.
		
	By:	 	 /s/ Kenneth Klein

		 	Name:	 	Kenneth Klein
			
		 	Title:	 	Chief Financial Officer
		
	By:	 	 /s/ Matthew Maruca

		 	Name:	 	Matthew Maruca
			
		 	Title:	 	General Counsel



  
 18 








 Schedule “A” to the Treasury Share Direction 

 

													
	 Registration
	  	 Address of registration
	  	Number of Treasury
Shares	 	  	Acquisition
Date	  	Acquisition Price (USD)	 
	 Christopher H. Lloyd
	  		  	 	1,077,312	  	  	June 30, 2015	  	$	6.80	  
	 The Wells Children’s Irrevocable Trust
	  		  	 	28,268	  	  	June 30, 2015	  	$	6.80	  
	 The Vance Wells Irrevocable Asset Trust
	  		  	 	268,542	  	  	June 30, 2015	  	$	6.80	  
	 The Kym Wells Irrevocable Asset Trust
	  		  	 	268,542	  	  	June 30, 2015	  	$	6.80	  
	 Vance Wells
	  		  	 	38,361	  	  	June 30, 2015	  	$	6.80	  
	 The Ganss Irrevocable Trust
	  		  	 	28,268	  	  	June 30, 2015	  	$	6.80	  
	 The Steven Ganss Irrevocable Asset Trust
	  		  	 	268,542	  	  	June 30, 2015	  	$	6.80	  
	 The Amy Ganss Irrevocable Irrevocable Asset Trust
	  		  	 	268,542	  	  	June 30, 2015	  	$	6.80	  
	 Steven Ganss
	  		  	 	38,361	  	  	June 30, 2015	  	$	6.80	  
	 Alex Noffsinger
	  		  	 	531,293	  	  	June 30, 2015	  	$	6.80	  
	 Nick Lloyd
	  		  	 	158,746	  	  	June 30, 2015	  	$	6.80	  
	 Tyler Holland
	  		  	 	158,746	  	  	June 30, 2015	  	$	6.80	  
	 Lew Lefko
	  		  	 	42,772	  	  	June 30, 2015	  	$	6.80	  
	 Brett Lamb
	  		  	 	173,049	  	  	June 30, 2015	  	$	6.80	  
	 Doug Johnson
	  		  	 	64,313	  	  	June 30, 2015	  	$	6.80	  









															
	 Registration
	  	 Address of registration
	  	Number of Treasury
Shares	 	  	Acquisition
Date	 	  	Acquisition Price (USD)	 
	 Chris Smith
	  		  	 	6,874	  	  	 	June 30, 2015	  	  	$	6.80	  
	 John Lookabaugh
	  		  	 	13,748	  	  	 	June 30, 2015	  	  	$	6.80	  
	 Jonathan Herland
	  		  	 	6,874	  	  	 	June 30, 2015	  	  	$	6.80	  
	 Greg Campbell
	  		  	 	4,812	  	  	 	June 30, 2015	  	  	$	6.80	  
	 Brad Nelson
	  		  	 	6,874	  	  	 	June 30, 2015	  	  	$	6.80	  
	 Keith Crider
	  		  	 	10,311	  	  	 	June 30, 2015	  	  	$	6.80	  
	 Chris Quinn
	  		  	 	6,874	  	  	 	June 30, 2015	  	  	$	6.80	  
	 Erin Bouck
	  		  	 	13,748	  	  	 	June 30, 2015	  	  	$	6.80	  
	 Chance McElhaney
	  		  	 	141,628	  	  	 	June 30, 2015	  	  	$	6.80	  
	 Cottonwood Family Trust
	  		  	 	145,906	  	  	 	June 30, 2015	  	  	$	6.80	  
	 Melanie Gross
	  		  	 	59,331	  	  	 	June 30, 2015	  	  	$	6.80	  
		  		  	  
	  
	 	  				  			
		  		  	 	3,830,637	  	  				  			
		  		  	  
	  
	 	  				  			

 LEGEND TEXT: 
 UNLESS
PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE [            ], 2015. 

THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE LISTED ON THE TORONTO STOCK EXCHANGE (“TSX”); HOWEVER, THE SAID SECURITIES CANNOT BE TRADED
THROUGH THE FACILITIES OF TSX SINCE THEY ARE NOT FREELY TRANSFERABLE, AND CONSEQUENTLY ANY CERTIFICATE REPRESENTING SUCH SECURITIES IS NOT “GOOD DELIVERY” IN SETTLEMENT OF TRANSACTIONS ON TSX. 

THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “U.S. SECURITIES ACT”) OR
STATE SECURITIES LAWS. THE HOLDER HEREOF, BY PURCHASING SUCH SECURITIES, AGREES FOR THE BENEFIT OF THE ISSUER THAT SUCH SECURITIES MAY BE OFFERED, SOLD OR OTHERWISE TRANSFERRED ONLY (A) TO THE ISSUER, (B) OUTSIDE THE UNITED STATES IN ACCORDANCE WITH
REGULATION S UNDER THE U.S. SECURITIES ACT, (C) INSIDE THE UNITED STATES IN 

  
 20 








 
ACCORDANCE WITH RULE 144A UNDER THE U.S. SECURITIES ACT, (D) PURSUANT TO THE EXEMPTION FROM REGISTRATION UNDER THE U.S. SECURITIES ACT PROVIDED BY RULE 144 THEREUNDER AFTER PROVIDING A LEGAL
OPINION SATISFACTORY TO THE ISSUER, (E) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT THAT REGISTERS THE RESALE OF SUCH SECURITIES OR (F) PURSUANT TO ANOTHER EXEMPTION FROM REGISTRATION AFTER PROVIDING A LEGAL OPINION SATISFACTORY TO THE
ISSUER. HEDGING TRANSACTIONS INVOLVING THE SECURITIES REPRESENTED HEREBY MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH U.S. SECURITIES LAWS. 

  
 21 








 Schedule 4 

Allocation of Withheld Shares among Athas Sellers 
  

					
	 Name
	  	Withheld Shares	 
	 Chris Lloyd
	  	 	369,196	  
	 Vance Wells
	  	 	7,326	  
	 The Wells Children’s Irrevocable Trust
	  	 	5,398	  
	 The Vance Wells Irrevocable Asset Trust
	  	 	51,283	  
	 The Kym Wells Irrevocable Asset Trust
	  	 	51,283	  
	 Steven Ganss
	  	 	7,326	  
	 The Ganss Irrevocable Trust
	  	 	5,398	  
	 The Steven Ganss Irrevocable Asset Trust
	  	 	51,283	  
	 The Amy Ganss Irrevocable Asset Trust
	  	 	51,283	  
	 Alex Noffsinger
	  	 	102,474	  
	 Nick Lloyd
	  	 	24,098	  
	 Tyler Holland
	  	 	24,098	  
	 Lew Lefko
	  	 	6,150	  
	 Brett Lamb
	  	 	9,795	  
	 Doug Johnson
	  	 	14,049	  
	 Christopher Smith
	  	 	—  	  
	 John Lookabaugh
	  	 	—  	  
	 Jonathan Herland
	  	 	—  	  
	 Greg Campbell
	  	 	—  	  
	 Brad Nelson
	  	 	—  	  
	 Keith Crider
	  	 	—  	  
	 Chris Quinn
	  	 	—  	  
	 Erin Bouck
	  	 	—  	  
	 Chance McElhaney
	  	 	20,359	  
	 Cottonwood Family Trust
	  	 	31,872	  
	 Melanie Gross
	  	 	3,358	  
		  	  
	  
	 
		  	 	836,029